Puma Biotech (PBYI) Tops Q4 EPS by 95c, Beat on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 10.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.22 | 52 Week High | $82.81 | |||
| Open | $10.22 | 52 Week Low | $19.74 | |||
| Day High | $10.22 | P/E | N/A | |||
| Day Low | $10.22 | EPS | $-2.16 | |||
| Volume | 115 | |||||
